Drugs / Allogenic human purified pancreatic islets
Allogenic human purified pancreatic islets
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00468117 | Jan 2007 → Jul 2015 | type 1 diabetes mellitus | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogenic human purified pancreatic islets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00468117 ↗ |
| Modality | Cell therapy | “islet transplantation” NCT00468117 ↗ |
| Route | Intravenous | “infusion of islets into a branch of the portal vein” NCT00468117 ↗ |